Non-Profit - N/A, N/A, GB
IFFIm is a vital funding component of Gavi, the Vaccine Alliance. A pioneer in impact investing, IFFIm issues vaccine bonds on the capital markets against long-term pledges from sovereign donors. Vaccine bonds have raised nearly US$ 8 billion from investors, making large volumes of funds immediately available for immunisation programmes. This saves more lives, and faster.For Gavi, the proceeds of vaccine bonds help ensure predictable funding and efficient operations. In addition, Gavi can frontload funds when necessary for rapid roll-out of new and underused vaccines. For example, IFFIm funds enabled Gavi to stimulate country demand for the five-in-one pentavalent vaccine, enlarging the size of the market, attracting new manufacturers and reducing prices. It has also helped respond to the COVID-19 pandemic by constibuting US$ 975 million to the COVAX AMC.For investors, vaccine bonds are a "pure play" impact investment providing a unique opportunity to realise an attractive and secure rate of return and diversify portfolios while helping save lives. IFFIm has played a leading role in developing social bonds and has been praised as a success story, earning recognition from the UN, World Bank, G8, Organisation for Economic Co-operation and Development (OECD) and Financial Times among others. IFFIm's work has received multiple awards since its founding. EuroWeek magazine cited IFFIm's 2008 inaugural "uridashi" bond issue in Japan as among the 25 most influential deals between 2007-2012, helping set a trend of ethically themed bonds sold in Japan. IFFIm's debut sukuk was awarded Social Impact Deal of the Year-2014 by Islamic Finance News, and "Islamic Finance D
Outlook
Varnish
Mobile Friendly
Amazon AWS
YouTube